Clinical Trials Logo

Shoulder Joint Disease clinical trials

View clinical trials related to Shoulder Joint Disease.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02043132 Completed - Clinical trials for Blood Loss, Surgical

Tranexamic Acid in Reverse Total Shoulder Arthroplasty

TXA
Start date: September 2013
Phase: Phase 2/Phase 3
Study type: Interventional

To the Investigators' knowledge, TXA has not been studied in the setting of reverse total shoulder arthroplasty. We propose a double-blinded, randomized, controlled trial comparing perioperative administration of TXA to placebo in the setting of RTSA. The purpose of this study is to examine the efficacy of TXA in reducing overall blood loss and transfusion rates in patients undergoing reverse total shoulder arthroplasty.